$2.68
-0.22[-7.59%]
At close: Apr 19
$2.68
0[0.00%]
After Hours: 4:33PM EDT
PDS Biotechnology
(NASDAQ:PDSB)PDS Biotechnology Stock (NASDAQ:PDSB), Analyst Ratings, Price Targets, Predictions
PDS Biotechnology Corp has a consensus price target of $18.6, established from looking at the 24 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, HC Wainwright & Co., and Oppenheimer on March 28, 2024, March 27, 2024, and November 15, 2023. With an average price target of $17.33 between B. Riley Securities, HC Wainwright & Co., and Oppenheimer, there's an implied 546.77% upside for PDS Biotechnology Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
B. Riley Securities
HC Wainwright & Co.
Oppenheimer
Chardan Capital
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for PDS Biotechnology
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/28/2024 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 310.45% | B. Riley Securities | Kalpit Patel | $14 → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | $21 → $21 | Maintains | Buy | Get Alert |
| 11/15/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 646.27% | Oppenheimer | Leland Gershell | $23 → $20 | Maintains | Outperform | Get Alert |
| 10/11/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | Buy → Buy | Get Alert |
| 09/27/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 795.52% | Oppenheimer | Leland Gershell | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 05/26/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 795.52% | Oppenheimer | Leland Gershell | → $24 | Reiterates | → Outperform | Get Alert |
| 04/24/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | → Buy | Get Alert |
| 03/30/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 347.76% | B. Riley Securities | Kalpit Patel | → $12 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | → $21 | Maintains | Buy | Get Alert |
| 01/03/2023 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 683.58% | HC Wainwright & Co. | Joseph Pantginis | $15 → $21 | Maintains | Buy | Get Alert |
| 11/15/2022 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 497.01% | Chardan Capital | Geulah Livshits | $15 → $16 | Maintains | Buy | Get Alert |
| 11/01/2022 | PDSB | Buy Now | PDS Biotechnology | $2.68 | 273.13% | B. Riley Securities | Kalpit Patel | → $10 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for PDS Biotechnology (PDSB)?
The latest price target for PDS Biotechnology (NASDAQ: PDSB) was reported by B. Riley Securities on March 28, 2024. The analyst firm set a price target for $11.00 expecting PDSB to rise to within 12 months (a possible 310.45% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PDS Biotechnology (PDSB)?
The latest analyst rating for PDS Biotechnology (NASDAQ: PDSB) was provided by B. Riley Securities, and PDS Biotechnology reiterated their buy rating.
When was the last upgrade for PDS Biotechnology (PDSB)?
There is no last upgrade for PDS Biotechnology.
When was the last downgrade for PDS Biotechnology (PDSB)?
There is no last downgrade for PDS Biotechnology.
When is the next analyst rating going to be posted or updated for PDS Biotechnology (PDSB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PDS Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PDS Biotechnology was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.
Is the Analyst Rating PDS Biotechnology (PDSB) correct?
While ratings are subjective and will change, the latest PDS Biotechnology (PDSB) rating was a reiterated with a price target of $14.00 to $11.00. The current price PDS Biotechnology (PDSB) is trading at is $2.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.